FDA to review Biodel diabetes drug candidate VIAject

Malaysia News.Net
Monday 1st March, 2010 (Source: Star Tribune)

DANBURY, Conn. - Biodel Inc. said Monday the Food and Drug Administration will review the biotechnology company's diabetes drug candidate VIAject.

VIAject is a type of human insulin designed to be a... ...

Read the full story at Star Tribune

Have your say on this story